IMPAIRED ELIMINATION OF METRONIDAZOLE IN DECOMPENSATED CHRONIC LIVER-DISEASE

被引：1

作者：

DANESHMEND, TK ^{[1
]}

ROBERTS, CJC ^{[1
]}

机构：

[1] UNIV BRISTOL,BRISTOL ROYAL INFIRM,DEPT MED,BRISTOL BS2 8HW,AVON,ENGLAND

来源：

BRITISH MEDICAL JOURNAL | 1984年 / 288卷 / 6414期

关键词：

D O I：

10.1136/bmj.288.6414.405

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：405 / 405

页数：1

共 5 条

[1] DISPOSITION OF ORAL METRONIDAZOLE IN HEPATIC CIRRHOSIS AND IN HEPATOSPLENIC SCHISTOSOMIASIS [J].

DANESHMEND, TK ;

HOMEIDA, M ;

KAYE, CM ;

ELAMIN, AA ;

ROBERTS, CJC .

GUT, 1982, 23 (10) :807-813

[2] IMPAIRED ELIMINATION OF METRONIDAZOLE IN DECOMPENSATED CHRONIC LIVER-DISEASE [J].

FARRELL, G ;

ZALUZNY, L ;

BAIRDLAMBERT, J ;

CVEJIC, M ;

BUCHANAN, N .

BRITISH MEDICAL JOURNAL, 1983, 287 (6408) :1845-1845

[3] RECTAL ADMINISTRATION OF METRONIDAZOLE PROVIDES THERAPEUTIC PLASMA-LEVELS IN POSTOPERATIVE-PATIENTS [J].

IOANNIDES, L ;

SOMOGYI, A ;

SPICER, J ;

HEINZOW, B ;

TONG, N ;

FRANKLIN, C ;

MCLEAN, A .

NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (26) :1569-1570

[4] TREATMENT OF HEPATIC-ENCEPHALOPATHY WITH METRONIDAZOLE [J].

MORGAN, MH ;

READ, AE ;

SPELLER, DCE .

GUT, 1982, 23 (01) :1-7

[5] CLINICAL PHARMACOKINETICS OF METRONIDAZOLE [J].

RALPH, ED .

CLINICAL PHARMACOKINETICS, 1983, 8 (01) :43-62

← 1 →